UCP2 and type 2 diabetes mellitus: This acute regulatory effect of UCP2 on beta cell function is consistent with the relatively strong GSIS exhibited by the first-established Ucp2-ablated mouse strain [14], which suggested a pathological role for UCP2 in the development of beta cell dysfunction and Type 2 diabetes [15].